PSY187 - THE QUANTITY AND QUALITY OF EVIDENCE SUPPORTING EUROPEAN MARKETING AUTHORISATION OF ORPHAN DRUGS- COMPARISON OF RARE ONCOLOGY VERSUS RARE DISEASE

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2761
https://www.valueinhealthjournal.com/article/S1098-3015(18)36063-7/fulltext
Section Title :
Section Order : 2115
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36063-7&doi=10.1016/j.jval.2018.09.2761
HEOR Topics :
Tags :
Regions :